Implementation path design and policy recommendations for importing unregistered drugs for rare disease through cross-border e-commerceLIU Zhao, XIANG Gui-yuan, ZHANG Fan, ZHENG Jia-yin, LIU Yue-hua, ZHAO Kun441-447
Technical intelligence analysis of cell immunotherapy in cancer based on patented mapLIU Yue, LI Xue, ZENG Ying-ying, YUAN Hong-mei448-454
Study on Hub-and-Spoke model as biotech startup and its enlightenmentYANG Shu-jun, YU Ying-hui, ZHOU Bin455-461
Consideration and suggestion on bioequivalence standard of mesalamineLIU Xin, JU Ge-hang, WANG Xin-tong, CHEN Lu-lu, OUYANG Dong-sheng462-468
Oliceridine: a new drug for the treatment of moderate to severe acute pain in adultsWU Xi-min, ZHANG Xiao-jing, FENG Mi, CHANG Hui-li469-475
Introduction to selection and management of reference listed drug for chemical generic drugs in ChinaZHANG Zhuo-cheng, LI Fang, AN Na, TU Jia-sheng, SUN Chun-meng, NING Li-li476-480
Toxicity studies of benvitimod after single dose administration and repeated dose administrationSUN Li, Li Jian-xiong, LIU Quan-hai, LIU Min-yu481-491
Progress of anti-hepatic fibrosis medicines in clinical trialsNIU Wei-ping, HE Hong-wei, WANG Ju-xian, WANG Yu-cheng492-500
Progress in clinical application of sodium-glucose cotransporter 2 inhibitors in cardiovascular fieldSHU Bing, CHEN Long-wei, SHEN Ai-zong501-506
Application value of FENO in AECOPD patients with systemic glucocorticoidsYANG Yi-cheng, DING Guo-zheng507-512